# 4D Molecular Therapeutics, Inc.: Form S-1, filed Sep 30, 2019

- Company: [4D Molecular Therapeutics, Inc.](/companies/fdmt.md) (CIK 1650648)
- Form: S-1
- Filed: 2019-09-30
- Accepted by EDGAR: Sep 30, 2019, 17:12 ET
- Period: not reported
- Accession: 0001193125-19-258924
- Inline XBRL: no
- Main document: https://www.sec.gov/Archives/edgar/data/1650648/000119312519258924/d781613ds1.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1650648/000119312519258924/

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1650648/000119312519258924/d781613ds1.htm

Filed Sep 30, 2019.
Source: SEC EDGAR, the filing index for accession 0001193125-19-258924. Last ingested by Listed: Nov 13, 2026, 16:07 ET. No prices; not investment advice.